After graduating from BYU, Stephen has charted an unusual path in the biotech industry. He’ll talk about this journey, career options in the biopharma space, and what he’s up to now at Curebase.
Stephen is an Associate Director of Business Development at Curebase, a fast-growing startup that’s running the next generation of clinical trials. Earlier this year, Curebase raised a $40M Series B with VC investors and industry partners, including Gilead Sciences. They have supported more than 60 studies to date, including multiple successful FDA submission studies.
Curebase
Associate Director of BD
Stephen works on the Business Development team at Curebase - a company that runs clinical trials. Before working at Curebase, he worked in Operations at Amgen doing lifecycle management and product development for one of its largest oncology products. While working at Amgen he completed a master's degree at Johns Hopkins in biotech business.
Stephen works on the Business Development team at Curebase - a company that runs clinical trials. Before working at Curebase, he worked in Operations at Amgen doing lifecycle management and product development for one of its largest oncology products. While working at Amgen he completed a master's degree at Johns Hopkins in biotech business.
CCS Growth Partners
ISTARI
McKinsey
Board Member, BYU MS Boston Chapter
Johnston Co.
President, BYU MS Boston Chapter
CCS Growth Partners
Board Member/Treasurer, BYU MS Boston Chapter
Curebase
Board Member, BYU MS Boston Chapter
